Product Program year 2025 Source: CMS Open Payments

Flexitron HDR

Device Brachy Solutions

PDI 08717213051126

Open in the dashboard

General payments

$628,570

334 payments

Research payments

$257,037

17 payments

Through program year 2025, $628,570 in general payments and $257,037 in research payments were reported against Flexitron HDR (Brachy Solutions).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Amount Payments
2025 General $193,302 139
2025 Research $108,582 10
2024 General $184,349 45
2024 Research $148,455 7
2023 General $107,661 40
2022 General $140,728 69
2021 General $2,531 41

Breakdown

Who paid General payments · program years 2021–2025
  1. Nucletron Operations B.V. $378,517 49 payments
  2. Elekta, Inc. $180,114 271 payments
  3. Nucletron B.V. $69,778 11 payments
  4. Elekta Medical S.A. de C.V. $97 2 payments
  5. Elekta Medical Systems Ltda $64 1 payment
Top recipients General payments · program year 2025
  1. Barbara Schwartzberg Denver, CO $81,931 42% · 14 payments
  2. Ronald Reagan Ucla Teaching hospital · CA $57,631 30% · 8 payments
  3. Jonathan Cheng Radiation Oncology · Baytown, TX $19,826 10% · 8 payments
  4. Stephen Doggett Radiation Oncology · Newport Beach, CA $10,867 6% · 3 payments
  5. Ut Md Anderson Cancer Center Teaching hospital · TX $9,860 5% · 3 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Radiation Oncology Radiology $40,862 94% · 24 practitioners
  2. Dermatology $1,595 4% · 43 practitioners
  3. Physician Assistant $443 1% · 9 practitioners
  4. MOHS-Micrographic Surgery Dermatology $246 <1% · 5 practitioners
  5. Procedural Dermatology Dermatology $154 <1% · 4 practitioners

The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Colorado $81,931 42% · 1 recipient
  2. California $68,698 36% · 4 recipients
  3. Texas $31,012 16% · 35 recipients
  4. Pennsylvania $7,776 4% · 5 recipients
  5. North Carolina $1,529 <1% · 2 recipients

The top 5 of 21 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

334 general · 17 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record